LASA SUPERGENERICS
Back to Balance Sheet
|
LASA SUPERGENERICS Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Contingent Liabilities | - | - | - | - | - |
What is the latest Contingent Liabilities ratio of LASA SUPERGENERICS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | - |
| Mar2021 | - |
| Mar2020 | - |
How is Contingent Liabilities of LASA SUPERGENERICS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2024 | - | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | 0 | |
| Mar2021 | - | 0 | |
| Mar2020 | - | - | |
Compare Contingent Liabilities of peers of LASA SUPERGENERICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LASA SUPERGENERICS | ₹41.9 Cr | -1.3% | 10.1% | -50.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹403,052.0 Cr | 0.3% | -3.7% | -4.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,336.0 Cr | 2.4% | 6.7% | 11.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,311.0 Cr | -0.8% | -1.5% | 25.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,264.0 Cr | 7.9% | 4.6% | 4.6% | Stock Analytics | |
| CIPLA | ₹105,484.0 Cr | 5.5% | 5.4% | -18.5% | Stock Analytics | |
LASA SUPERGENERICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LASA SUPERGENERICS | -1.3% |
10.1% |
-50.5% |
| SENSEX | -0.4% |
1.3% |
0.8% |
You may also like the below Video Courses